SLC25A32 and glioblastoma: Notably, we obtained mutation frequency data that are almost consistent with the UALCAN database because both have high SLC25A32 mutation frequency (Figure 4(c)) in lung adenocarcinoma, endometrial, HNSC, stomach, breast, colorectal, glioblastoma, and ovarian serous cystadenocarcinoma (OV).